Chinese PLA General Hospital
USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Chinese ranks #28,409 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.
- #28,409
- of 49,997 US assignees by volume
- Top 23%
- by Innovation Score (45.5/100)
- 9.7
- avg claims per patent
- +67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R28409 · Foreign Government #28,409 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNGOV · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 9 grants
- MID-PACK #28,409/49,997
- PHOTO-FINISH Cheng YU Enterprises
- CPC-FOCUS A61P · 11 areas
- INNOV-PAR 45.5/100
- CLAIMS-PAR 9.7 claims/avg
- TYPE-FRNGOV Foreign Gov
- VEL-SURGE +67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cheng YU Enterprises Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Chinese’s 45.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Chinese
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Chinese PLA General… · this assignee
Chinese PLA General… · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Chinese's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Chinese?
Each dot is one of Chinese’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chinese’s own 9.7 claims/patent is at or below the 15.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Chinese's grants concentrate
Chinese PLA General Hospital is a focused PatentsView assignee: 11 CPC subclasses with 55.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2015. By volume, Chinese sits between Cheng YU Enterprises Co., Ltd. and Chongqing Advance Display Technology Research.
Chinese's three-year grant acceleration
Chinese PLA General Hospital shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Chinese's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cheng YU Enterpri…
Cheng YU Enterprises Co., Ltd.
9 patents
- Chengdu Borns Med…
Chengdu Borns Medical Robotics Inc.
9 patents
- Chengdu Haiguang…
Chengdu Haiguang Integrated Circuit Design Co., Ltd.
9 patents
- China National Re…
China National Research Institute OF Food & Fermentation Industries Co., Ltd.
9 patents
- Chinoin GYÓGyszer…
Chinoin GYÓGYSZER ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZRT.
9 patents
- Chipolo D O O
Chipolo, D.O.O.
9 patents
- Chong
Chong Corporation
9 patents
- Chongqing Advance…
Chongqing Advance Display Technology Research
9 patents
- Chinese PLA Gener… ◀
Chinese PLA General Hospital
9 patents
What this shows Chinese holds 9 patents at rank #28,364, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Chinese
By rank, the assignees closest to #28,364 in granted patent volume.
- Cheng YU Enterprises Co., Ltd. #28,360 · 9 patents
- Chengdu Borns Medical Robotics Inc. #28,361 · 9 patents
- Chengdu Haiguang Integrated Circuit Design Co., Ltd. #28,362 · 9 patents
- China National Research Institute OF Food & Fermentation Industries Co., Ltd. #28,363 · 9 patents
- Chinoin GYÓGYSZER ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZRT. #28,365 · 9 patents
- Chipolo, D.O.O. #28,366 · 9 patents
- Chong Corporation #28,367 · 9 patents
- Chongqing Advance Display Technology Research #28,368 · 9 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Chinese's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Chinese's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 23% higher than 77% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 11.1% |
| 2016 | 2 | 22.2% |
| 2022 | 1 | 11.1% |
| 2023 | 3 | 33.3% |
| 2024 | 1 | 11.1% |
| 2025partial year | 1 | 11.1% |
Which technologies does Chinese PLA General Hospital patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Chinese PLA General Hospital's patent record in context - here's where to go next.
- Chinese PLA General Hospital's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 55.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #28,409 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Chinese PLA General Hospital against Cheng YU Enterprises Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.